KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Total Current Liabilities (2018 - 2025)

Castle Biosciences (CSTL) has disclosed Total Current Liabilities for 8 consecutive years, with $68.7 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 39.04% to $68.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $68.7 million through Dec 2025, up 39.04% year-over-year, with the annual reading at $68.7 million for FY2025, 39.04% up from the prior year.
  • Total Current Liabilities hit $68.7 million in Q4 2025 for Castle Biosciences, up from $55.3 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $68.7 million in Q4 2025 to a low of $17.6 million in Q1 2021.
  • Historically, Total Current Liabilities has averaged $37.1 million across 5 years, with a median of $36.2 million in 2022.
  • Biggest five-year swings in Total Current Liabilities: crashed 33.95% in 2021 and later surged 124.83% in 2022.
  • Year by year, Total Current Liabilities stood at $24.9 million in 2021, then surged by 45.17% to $36.1 million in 2022, then skyrocketed by 31.94% to $47.7 million in 2023, then increased by 3.62% to $49.4 million in 2024, then skyrocketed by 39.04% to $68.7 million in 2025.
  • Business Quant data shows Total Current Liabilities for CSTL at $68.7 million in Q4 2025, $55.3 million in Q3 2025, and $50.9 million in Q2 2025.